Concepedia

Sumiko Shingo

SS

Statistics

Publications

13

Citations

838

H-Index

13

Active since

1993

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

KU Leuven

Sumiko Shingo is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, clinical pharmacology, and pharmacotherapy.

Publications per year

1993–2005

13

Publications

13

Oral Leukotriene Inhibitor (MK-886) Blocks Allergen-induced Airway Responses

Beth S. Friedman, Elizabeth H. Bel, A. Buntinx et al. · American Review of Respiratory Disease · 1993 · 161 citations

, , +15

A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene–receptor antagonist

Leonard C. Altman, Zev M. Munk, James M. Seltzer et al. · Journal of Allergy and Clinical Immunology · 1998 · 148 citations · Full text

, , +6

Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged ≥ 6 years

William W. Storms, Theresa M. Michele, Barbara Knorr et al. · Clinical & Experimental Allergy · 2001 · 85 citations

, , +12

Correlation of airway obstruction and patient-reported endpoints in clinical studies

Sumiko Shingo, J. Zhang, T.F. Reiss · European Respiratory Journal · 2001 · 83 citations · Full text

, , +13

Renal effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs in controlled clinical trials

Sean Curtis, Jennifer Ng, Qinfen Yu et al. · Clinical Therapeutics · 2004 · 81 citations

, , +15

1–5 of 13